Genmab — November 2020

E_L

yes, i heard that , but i stopped after 1/2 hour, because they did not follow the presentation anymore, too long to sit through everything, i was wondering if they said more later on, on the number of subscriptions

E_L

in the presentation it reads : 95%+ (~6000) of MS prescribing targets reached

E_L

Solsen thought that means 6,000 prescriptions, I am not so sure, so hoping for clarification

GeorgeBest

E L - why not post a question for Fridays q/a

E_L

yes, i can try, if nobody here knows. Doubt he'll answer that though

Solsen

Well I dont know. More likely its the number of physicians Novartis salesforce are targeting.

Solsen

Wonder what 5,2% NBRx is in numbers - New of brand presciptions ?

Helge_LarsenPI-redaktør

Hej alle, Er virkelig seriøst bagud på spørgsmål til Q&A fredag. Læg dem endelig ind i aften eller i morgen eller senest fredag formiddag. På forhånd tak.

Solsen

Jeg har fri i morgen så jeg skal nok fylde på

E_L

if my guestimate for Ocrevus is roughly correct at new patients 5,000 for 10 weeks in the US then i thought it should be at least 260? I am probably doing this completely wrong... 260 patients would bring $26mio in revenue in 1 year

E_L

I don't think i have much for QA, most of my questions were answered in the last few weeks.... and Enapotamab Q
yesterday lol

Helge_LarsenPI-redaktør

Thanks guys. I can always count on you.

Helge_LarsenPI-redaktør

God morgen.

Plimsoller

God morgen

deleted-user

Q&A - Er der spørgsmål omkring ensretning mellem "aktierne" i Danmark og US 1:10?

deleted-user

Q&A - spørgsmål omkring Genmab' kapitalbehov? Balance mellem kapitalbehov til udvikling af pipeline og kurspleje ved dividende
?

GeorgeBest

Bare stil dine spørgsmål i Q/A chatten, så kan Helge udelade det hvis der er lignende spørgsmål fra en anden. Kvaliteten af Q/A højnes, hvis Helge har flere Qs at vælge i mellem.

deleted-user

Er det fanen "Q&A Gen ... 11-27"? Som pt. er tom?

Sukkeralf

jep

deleted-user

Tak. Vel mødt i morgen kl. 16.00